Outsourcing channel feed – Endpoints News

Outsourcing channel feed

Drug manufacturing giant Lonza taps Roche/pharma ‘reinvention’ vet as its new CEO

5 years ago

GSK inks $231M manufacturing deal as Hal Barron anticipates fruitful year for pruned R&D group

5 years ago

Ally Bridge joins Bain in $120M bet that speeding up manufacturing QC can hit big in post-pandemic world

5 years ago

Theft victim or data bully? IQVIA exchanges blows with small rival it says destroyed evidence in legal fight

6 years ago

Catalent chief John Chiminski triggers a $315M-plus wager on the booming cell therapy market now in the making

6 years ago

Deerfield vaults to the top of cell and gene therapy CDMO game with $1.1B facility at Philadelphia's newest biopharma hub

6 years ago

Korea's Celltrion blueprints $514M biologics plant in China, beefing up biosimilar, contract manufacturing

6 years ago

What are biopharma companies hiring CROs for these days? PPD spells it out in bid for $100M IPO

6 years ago

Preparing for new wave of treatments, Fujifilm drops $55 million for gene therapy center

6 years ago

China's Fountain Medical scores $62M as demand for CRO services surges

6 years ago

Parexel embraces real world evidence, enlisting Datavant to drill it into CRO workflow

6 years ago

Permira proposes to take Cambrex private in $2.4B deal, stirring up CDMO M&A

6 years ago

Beefing up its new gene therapy unit, Catalent inks $18M deal to snap up Novavax facilities

6 years ago

'It's a growth play': Catalent acquires Bristol-Myers' European launch pad, expanding global CDMO ops

6 years ago

'Sophisticated' cyberthieves hacked into Charles River Labs and made off with clients’ drug data

7 years ago

Nine listings and $3.8B later, HKEX celebrates one-year biotech anniversary with $194M CRO IPO

7 years ago

Ahead of US gene therapy explosion, big contract drug manufacturer Catalent makes $1.2 billion bet on Paragon Bioservices

7 years ago

AstraZeneca chops 210 workers, closes sites as it looks to concentrate biologics manufacturing in one place

7 years ago

WuXi AppTec files for public listing in Hong Kong four months after explosive Shanghai IPO

7 years ago

Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services

7 years ago

Clinical trial disruptor Science 37 in talks with SoftBank on a $150M investment — Recode

7 years ago

Listing in Shanghai, WuXi AppTec raises a $354M IPO for China R&D facilities

8 years ago

Tapping a biotech boom, China gene editing CRO Biocytogen bags $65M round for global expansion

8 years ago

Eyeing growth in regenerative medicine, Fujifilm spends $800M on two new members of its CDMO business

8 years ago

First page Previous page 4 5 678 Next page Last page